Followers | 48 |
Posts | 1181 |
Boards Moderated | 0 |
Alias Born | 04/20/2018 |
Tuesday, March 19, 2019 3:51:29 PM
I thought with limited marketing funds the company would focus on CaverStem/FemCelz brands and their awareness in order to build revenue, not advertising the company to get people to buy shares. Did our shareholder funds pay for that ad to sell shares?
I have no issue with CMTH/CELZ leadership promoting the company, if they have proved in writing they are truly building a strong company. Why are they advertising on IHub and not focusing the ad on the revenue generating procedures?
The IHub ad also brings us back to MeatSlice mentioning Don Dickerson potentially watching the board per his previous post. At first I didn't believe it as that would be a ridiculous waste of his time and make someone wonder about the companies true mission. Now that I see Dickerson and Warbington advertising the company on an investment website, used by many shareholders, it makes that thought not seem so out of line.
There are too many holes that unless you're drinking Kool-Aid and want to believe in Santa need to be addressed by CMTH/CELZ leadership.
One final point. If the procedure worked that great, there would be no need to advertise on an investment community site like IHub. It would catch fire and spread fast by word of mouth. Gershman has been performing this for over a year (according to him), yet there are no reviews on his site from pleased patients, nor the CaverStem site.
This isn't 1950. Men and women are more open today to discuss personal issues like mental health and sexual health. That's why talk shows devote so many segments to these key areas of human life. If a guy is able to improve his sex life at 50 because he had the CaverStem procedure when other things didn't work, that individual in most cases would have no problem going on TV with one of the CaverStem doctors like Gershman, to talk about how much of a difference CaverStem has made in their life.
I'd sign up today as you'd become the face of a movement to help men around the world naturally regain their sexual health. Not only would that individual become well knows and wealthy, more important, the company they represent (CMTH/CELZ) would be very valuable. Nothing drives demand and sales like PROOF of efficacy and testimonials.
It's time for CMTH/CELZ leadership to not focus energy and our resources on selling the company and shares via IHub, and put all the focus on driving revenue for CaverStem and FemCelz. And if you are going to use shareholder money to advertise on an investment community site, at least include the products you're selling front and center in that commercial to drive awareness and hopefully revenue.
At the end of the day, we all invested in a company we believe can do great things. I focused 6 months on being positive on the board, even when my gut was concerned about glaring issues which never have been addressed by CMTH/CELZ leadership when requested in writing. I am raising these issues with my 1 allowed daily post because they are important for the company to truly prosper. Too many things that have one scratching their head which leads to lack of trust and low volume.
Peace.
CF
Recent CELZ News
- Creative Medical Technology Holdings Announces Evolutionary Development of its iPSCelz® Program with the Successful Generation of iPSC Derived Islet Cells that Produce Human Insulin • GlobeNewswire Inc. • 06/24/2024 12:30:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/05/2024 08:05:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 08:02:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 08:45:39 PM
- Creative Medical Technology Holdings Provides Corporate Update • Business Wire • 03/27/2024 01:00:00 PM
- Creative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded Access • Business Wire • 03/07/2024 02:15:00 PM
- Biotech Finds Mid-Week Success Following FDA Announcement • AllPennyStocks.com • 03/06/2024 09:10:00 PM
- Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy • Business Wire • 03/06/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2023 09:05:37 PM
- Creative Medical Technology Holdings Provides Corporate Update • PR Newswire (US) • 11/15/2023 01:00:00 PM
- Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ ("CELZ-201-DDT") Novel Cell Therapy to Treat Chronic Lower Back Pain • PR Newswire (US) • 10/10/2023 12:00:00 PM
- Creative Medical Technology Holdings Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ (CELZ-201-DDT) for the Treatment of Chronic Lower Back Pain • PR Newswire (US) • 09/19/2023 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 08:45:38 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM